Skip to content
Agree.net – Lifestyle
Author:
Resolve Therapeutics, LLC
Resolve Therapeutics Presents Preclinical Data on NET Degradation and Nuclease Therapy in Acute Ischemic Stroke at the World Stroke Conference
October 21, 2026
Resolve Therapeutics Completes Enrollment in Phase 2 Study of RSLV-132 in Sjögren’s Disease
October 7, 2026